⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Cognitive Rehabilitation of Glioma Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Cognitive Rehabilitation of Glioma Patients

Official Title: Cognitive Rehabilitation of Glioma Patients: a Prospective, Randomized Study

Study ID: NCT00256425

Study Description

Brief Summary: The purpose of this study is to determine whether cognitive rehabilitation is effective in patients with gliomas (brain tumour), by comparing direct and follow-up neuropsychological functioning and quality of life of the experimental group to the control group.

Detailed Description: The majority of patients with (low-grade) glioma exhibit cognitive symptoms and objective deficits, which have a sustained, negative impact on daily functioning and quality of life. Adult patients with a low-grade glioma, either histologically proven, or suspected (1), as well as adult anaplastic glioma patients with favorable prognostic factors (2), who are clinically stable for at least 6 months, will be recruited from 9 hospitals in the Netherlands. Consenting patients with both subjective cognitive symptoms and objective deficits will be randomized to either the cognitive rehabilitation program (N = 75) or a "waiting-list" control group (N = 75). Upon completion of the study, those patients assigned to the control group will be given the opportunity to undergo the cognitive rehabilitation program. The cognitive rehabilitation program incorporates both retraining of impaired cognitive functions, and teaching of compensatory strategies. Rehabilitation will be directed towards attention, memory and executive functioning. The intervention will consist of 6 weekly, individual, 2-hour sessions plus two hours of homework. To evaluate the efficacy of the rehabilitation program, objective neuropsychological functioning, self-reported cognitive symptoms and health-related quality of life will be assessed before rehabilitation, directly following rehabilitation, and at 6-month follow-up.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

VU Medical Center, Amsterdam, , Netherlands

Netherlands Cancer Institute, Amsterdam, , Netherlands

Medical Center Haaglanden, Den Haag, , Netherlands

UMC Groningen, Groningen, , Netherlands

AZ Maastricht, Maastricht, , Netherlands

UMC St Radboud, Nijmegen, , Netherlands

Erasmus Medical Center, Rotterdam, , Netherlands

Sint Elisabeth Hospital, Tilburg, , Netherlands

University Medical Center Utrecht, Utrecht, , Netherlands

Contact Details

Name: Martin JB Taphoorn, MD, PhD

Affiliation: Medical Center Haaglanden

Role: PRINCIPAL_INVESTIGATOR

Name: Neil K Aaronson, PhD

Affiliation: The Netherlands Cancer Institute

Role: PRINCIPAL_INVESTIGATOR

Name: Margriet M Sitskoorn, PhD

Affiliation: UMC Utrecht

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: